49 Although an important trend in the overall reduction of symptom scores was demonstrated here, significant reduction of the individual symptom score was seen only for nasal itch. 49 In a separate study, individuals with severe SAR uncontrolled with 200 μg of FP once daily over 2 weeks were then randomized to 200 μg twice daily for a further 2 weeks. 50 This conferred a statistically significant advantage with increased symptom-free days in terms of decreased nasal congestion on waking and in the daytime.
← all excerpts
Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated.
1
—
—